FLAG-IDA as frontline induction improves outcomes in pediatric patients with core-binding factor or KMT2A-rearranged acute myeloid leukemia: A multicenter cohort study in southern China
Yongzhi Zheng(Fujian Medical University), Xiaoqin Feng(Nanfang Hospital), Chunfu Li(Chinese University of Hong Kong), Changgang Li(Nanfang Hospital), Yingyi He(Guangzhou Women and Children Medical Center), Sixi Liu(Shenzhen Children's Hospital), Huirong Mai(Shenzhen Children's Hospital), Jian Li(Guizhou University), Hong-Gui Xu(Sun Yat-sen University), Hong Wen(First Affiliated Hospital of Xiamen University), Huiping Li(Nanfang Hospital), Hua Jiang(University of Electronic Science and Technology of China), Keke Chen(Wuhan University), Lihua Yang(Second Affiliated Hospital of Nanjing Medical University), Nainong Li(Fujian Medical University), Mincui Zheng(Hunan Children's Hospital), Zhiyong Peng(Dongguan People’s Hospital), Xiangling He(Hunan Provincial People's Hospital), Lei Yu(Taiyuan Central Hospital)
Cited by 1
Related Papers
Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma
|Journal of Clinical Oncology|2011|644
Adjuvant Transarterial Chemoembolization for HBV-Related Hepatocellular Carcinoma After Resection: A Randomized Controlled Study
|Clinical Cancer Research|2018|355
<i>IDH</i> mutations predict longer survival and response to temozolomide in secondary glioblastoma
|Cancer Science|2011|296